---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-098773"
form_type: "8-K/A"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-07-25T23:59:59+00:00"
generated_at: "2026-05-18T01:13:58.649666+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tivic Health amends license deal with Statera; royalties payable in stock; lien up to $5.6M

## Summary
- Royalties may be paid in cash or Tivic securities at Tivic's discretion under the A&R License Agreement.
- Avenue Venture Opportunities Fund lien increased to up to $5.6 million (Payoff Amount).
- After initial fees and first milestone, 80% of subsequent payments go directly to Avenue until lien satisfied.
- Initial license fee already paid: $300K cash plus 945,785 common shares and convertible preferred shares.

## SEC filing metadata
- accession: 0000950170-25-098773
- form_type: 8-K/A
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-07-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025098773/0000950170-25-098773-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025098773/tivc-20250618.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-098773
- JSON: https://secwatch.observer/filing/0000950170-25-098773.json
- Plain text: https://secwatch.observer/filing/0000950170-25-098773.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.